Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • What oncologists really want from booth strategy

    August 19, 2025 | Congress, Inizio, oncology 

    - PMLiVE

    Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company 

    At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30 clients and delivering 185 projects, Inizio witnessed the shift toward smarter, more sustainable congress environments.

    Key takeaways included:

    • Oncologists want interactive learning: Engagement is moving beyond slides, with responsive booths, interactive LED walls, and digital-first experiences extending conversations well past the industry’s six-minute average.

    • Smart spaces are here to stay: With heat mapping, AI-powered personalization, and real-time content optimization, booths are evolving into dynamic, intelligent environments that adapt to audience needs.

    • Sustainability as strategy: Inizio’s circularity-first booth design delivered a 70% CO₂e reduction, 70.7% recyclability, and major cost savings – results that earned industry-leading awards and set a benchmark for measurable impact.

    In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are becoming essential to cut through the noise. The future of congress engagement will be intentional, data-informed, and deeply aligned with healthcare professionals’ learning preferences.

    Read Simon’s full article here, or explore more in Inizio’s on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    RP Investigates – Q&A session: Living with Lupus

    In this 45-minute session, Head of Living With, Mariel Metcalfe spoke to Brenda, who was diagnosed with Lupus 12 years ago.

    Webcast: Demand Assessment

    Find out how a study design which better reflects real-world choices can produce a more realistic model for the future market.

    White paper: Are we prepared for the influx of CAR-Ts?

    Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

    New syndicated patient report – Living with Lupus US

    Living with Lupus US is a new syndicated patient report which offers valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs.

    Video: Emotion AI

    Artificial intelligence is revolutionising the way we conduct healthcare market research.

    Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

    Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

    Webcast: Virtual Q&A session – The future of digital health

    In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

    Research Partnership is on the rise

    Research Partnership ranks 12th in fastest growing UK market research agency league  tables

    What does the future hold for Light-chain Amyloidosis?

    Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

    Webcast: Securing a future for telehealth with immersive market research insights

    Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.